Streetwise Reports' Article Archives — December 2021 back to current month (84)
Analyst: Drug a 'Hidden Gem for 2022' (12/31/2021)
Oppenheimer ranks Astria Therapeutics Outperform after learning about its drug for hereditary angioedema, saying "We stay bullish."
Why This Gold Newcomer Is a 'Strong Buy' (12/30/2021)
Sitka Gold Corp's recently released new drill results at its RC Gold Project in the Yukon have grabbed investors' attention.
Co.'s COVID-19 Test Detects Omicron Variant (12/30/2021)
H.C. Wainwright & Co. gives Sorrento Therapeutics a Buy rating after initial testing shows its COVISTIX detects COVID-19's Omicron variant.
Tech Firm Surging In Mobile Gaming Market (12/30/2021)
"Pixelworks represents a differentiated investment opportunity in video display processing capabilities," noted a ROTH Capital Partners report.
Why Red Metal Resources Is a Standout (12/30/2021)
With copper continuing to soar and Chile electing a new president opposed to open pit mines, Red Metal Resources is a compelling standout.
Co. Looks To US For Help Fighting Strokes (12/29/2021)
Canadian company Algernon Pharmaceuticals Inc. has applied to uplist to the Nasdaq in hopes of attracting U.S. investors to its mission to repurpose drugs.
Co. Still Compelling After Drug Trial Failure (12/29/2021)
"Arcalyst remains the value driver" for Kiniksa Pharmaceuticals, and "we continue to hold a favorable view of the company," noted a Wedbush report.
New CEO for Gold Terra: Gerald Panneton (12/28/2021)
Although Gerald Panneton was already guiding Gold Terra as an Executive Chairman, it seems likely after this restructuring he will have full control being a Chairman and CEO effective January 1st, 2022. As he was used to be thinking big at Detour, the Critical Investor expects more of the same here.
Counting Down the Top Drill Holes of 2021 (12/28/2021)
On any given business day, results from a drill hole can turn a Wednesday into Christmas Day for shareholders. We take a look at what experts think are the best drill holes of 2021.
Analyst Takes Year-End Stock of His Portfolio (12/28/2021)
In a year-end bulletin, Adrian Day gives a brief reminder of the fundamental reason for each stock in his portfolio, as well as to note the largest downside or risk for each.
Canadian Co. to Explore New Finnish Properties (12/28/2021)
After a year of slow progress for Avrupa Minerals, management decided to create more opportunities by acquiring four exploration properties in Finland.
Why Invest in This Uranium Explorer Now (12/27/2021)
In the Dec. 22 episode of Streetwise Live!, influential uranium investor Terry Papineau tells why he believes now is the right time to invest in the uranium sector and, specifically, in Baselode Energy. Its CEO James Sykes discusses the company's new high-grade discovery and its work plan for 2022.
Gold Mining to Commence at BC Project in Q1/22 (12/27/2021)
"The recovery of first gold from stage one of Omineca Mining and Metals' Wingdam placer project could be a major catalyst for the stock," noted a Research Capital report.
Silver Dollar Has Silver Eq at $.08 an Ounce (12/26/2021)
Bob Moriarty of 321Gold says that for astute investors, Silver Dollar Resources Inc. is a good bet into February regardless of what the rest of the market does.
"Cytokinetics' pipeline of muscle-directed therapies has potential to address several diseases with high unmet medical need and may generate significant revenue across pipeline programs," noted an Oppenheimer report.
A DawsonJames report notes that Brainstorm Cell Therapeutics’ autologous stem cells in amyotrophic lateral sclerosis will need further study to prove their effectiveness.
"With Acasti Pharma shares trading near cash levels yet current resources sufficient to achieve key development milestones across the pipeline over 2022-2023, we recommend investors build a position," noted an Oppenheimer report.
What differentiates NaturalShrimp is its proprietary technology that allows it to "produce recirculating aquaculture system-raised shrimp at a sufficient density for mass production," noted a ROTH Capital Partners report.
It's 'All Systems Go' for This Gold Co. (12/23/2021)
Chris Temple, editor and publisher of The National Investor, explains Omineca Mining & Metals' almost 50% increase and why his rationale for his initial recommendation of Omineca remains unchanged.
Nikola Corp. shares traded higher after the firm reported that Heniff Transportation Systems LLC signed a letter of intent to purchase 100 zero-emission trucks from Thompson Truck Center and Nikola.
Near Quesnel, B.C., a small Canadian company is about to take placer gold mining public. It’s been a long road, but it looks like British Columbia’s Cariboo region could see another gold rush more than 160 years after the first.
In a December 15 research note, H.C. Wainwright & Co. Equity Research Analysts Sameer Joshi and Amit Dayal commented that community and commercial solar power company UGE International Ltd. (UGE:TSX.V; UGEIF:OTCQB) is "positioned to capture value across the project lifecycle."
Industry observer Michael Ballanger explains why he has Western Uranium and Vanadium Corp. on his buy list.
Micron Technology Inc. shares traded 11% higher after the company reported Q1/22 financial results and stated that it was on a path toward record revenue and solid profitability in FY/22.
Analyst Highlights Top Picks in Biotech for 2022 (12/20/2021)
Aldeyra Therapeutics, in the ophthalmology space, and SQZ Biotechnologies, in the cell therapy sector, have "advantages that their specific approaches allow," noted a BTIG report.
Precious metals expert Michael Ballanger remembers lessons learned years ago from a three-year course in "Stocks and Bonds 101," and how those principles still apply today.
Intra-Cellular Therapies Inc. shares traded 19% higher to a new 52-week high after the company reported the U.S. FDA has approved the use of its CAPLYTA® (lumateperone) for treatment of adults with bipolar depression.
After Dolly Varden Silver announced the transaction with Fury Gold Mines regarding the Homestake Ridge Project, the Critical Investor looked into future potential coming from combining Homestake with the Dolly Varden Project, and exploration potential.
Shares of Bottomline Technologies Inc. traded 15% higher after the company reported it agreed to be acquired by private equity firm Thoma Bravo for $57.00 per share in cash.
Alico "offers a compelling opportunity" given expectations for increased production and pricing and continued dividends paid to shareholders, noted a ROTH Capital Partners report.
In this Dec. 15 episode of Streetwise Live! viewers learned about Datable Technology, what it does, why it is a compelling story and why two former Disney executives invested in it. They, Mike Ridgewell and Marc Reintjes, were on the panel along with Datable Chairman Kim Oishi and eResearch analyst Chris Thompson.
BioXcel Therapeutics' lead drug candidate for agitation in Alzheimer's disease patients could serve a substantial market, noted an H.C. Wainwright & Co. report.
Analyst Says Regeneron Could Be 'Biotech Champion' (12/17/2021)
Regeneron Pharmaceuticals Inc.'s stock was up 36% in 2021 while the NASDAQ Biotechnology Index remained flat, Oppenheimer analyst Hartaj Singh reported in a Dec. 16 research note.
Just in time for Christmas, one junior explorer drilling off concessions in a historic silver camp in Mexico is spinning its copper assets into a red metal play in northern British Columbia; and it just announced positive new drill results at its Mexico project.
The Critical Investor catches up with CEO Jason Weber of Alianza Minerals about the company's latest endeavors with Cloudbreak Discovery and the status of their other projects.
Co.'s Shares Gain 27% After FDA Nears Drug Approval (12/16/2021)
Shares of Calliditas Therapeutics AB traded higher after the company reported the U.S. FDA granted accelerated approval for its TARPEYO™ (budesonide) to reduce proteinuria in IgA nephropathy.
With the recently earned-in ownership of 51% in the Independence Gold project, the PEA coming up and potentially a much more important catalyst in Q1 2022, the Critical Investor felt it was time to conduct an interview with CEO Christos Doulis.
CMC Materials Inc. shares traded 33% higher after the semiconductor materials company reported it agreed to be acquired by Entegris Inc. in a combination cash and stock deal valued at approximately $6.5 billion.
Critical and precious metals explorer Aurania Resources Ltd. is methodically moving forward with is exploration program at its Lost Cities-Cutucu Project which has been shown to host significant amounts of zinc, copper, silver and other elements. Noble Capital Markets advised that the firm plans to begin exploration work at its Awacha target site in mid-December and is building momentum as it moves into 2022.
Companies Partner to Reach New Depths in Nevada (12/14/2021)
Nevada Exploration Inc. is looking to another local company to help shoulder the risk of gold exploration in the Silver State.
Terminix Global Holdings Inc. shares traded 18% higher after the company reported it has entered into a definitive agreement to be acquired by Rentokil Initial Plc. in a cash and stock transaction valued at US$6.7 billion, or about US$55/share.
During its recent R&D Day, Prometheus Biosciences announced new strong trial data, another new indication for its lead therapeutic candidate and progress in developing a subcutaneous formulation of it, according to an Oppenheimer report.
Omineca Mining and Metals will focus on the placer gold component of the Wingdam project throughout 2021 then next year also take on exploring the newly identified hardrock gold targets there, a Research Capital Corporation report noted.
Vancouver-based software and technology company Datable Technology Corp. is helping consumer packaged goods companies collect data from consumers who opt-in to their apps, promotions, contests, and loyalty programs. eResearch Corp. indicated that it is initiating coverage of the company with a "Speculative Buy" rating as it is now in the midst of a rapid revenue growth cycle.
Osisko Sees Record Revenues With Projects Advancing (12/13/2021)
Adrian Day, in the Global Analyst newsletter, updates recent results and developments at several companies, large and small, with some current buys among them.
Arena Pharmaceuticals shares traded 80% higher after the company reported it agreed to be acquired by Pfizer Inc. for $100.00 per share in cash in a deal valued at $6.7 billion.
Bob Moriarty of 321Gold shares his thoughts on Thesis Gold Inc.'s latest promising drill results at its Ranch Gold property in British Columbia.
F-star Therapeutics "has methodically delivered scientific/preclinical/early clinical data validating its platform bispecific technology," noted an Oppenheimer report.
Shares of global cloud infrastructure and enterprise software firm Oracle Corp. traded 16% higher after the company reported Q2/22 financial results that exceeded prior revenue guidance and non-GAAP earnings estimates.
In part two of a two-part series, Streetwise shares more insight from White Gold CEO and Director David D'Onofrio about the company's new and exciting discoveries that include the Betty property, which intercepted 3.46 g/t Au over 50m on its maiden diamond drilling program this year, and the Ryan’s Surprise/Ulli’s Ridge district.
As Metallic Minerals wraps up its exciting programs in the Keno Hill silver district, CEO and Chairman Greg Johnson explains why the future looks bright for silver.
Checkpoint Therapeutics' "cosibelimab represents a competitive asset on both efficacy and safety with an expected added advantage of lower net price," an H.C. Wainwright & Co. report noted.
The partnership allows Hansa Biopharma to "enter new markets without the cost and risk of building out country-specific commercial organizations for a single product," an H.C. Wainwright & Co. report indicated.
The market may need time to account for Kinross Gold's acquisition given Dixie's early, preresource stage despite the asset's seemingly large size potential, a Stifel GMP report noted.
"Silver X marks the spot in the junior silver producer sector with the Nueva Recuperada project," noted an Echelon Capital Markets report. "We see the current valuation as a potentially rewarding risk-return proposition."
A recent Haywood Securities industry report highlights the value proposition helium offers and discusses several helium pure plays that are positioned to take advantage of strong demand growth for the gas.
White Gold Corp. continues to deliver a steady flow of highly positive drill results and new discoveries at its 420,000 ha White Gold District property near Dawson City, Yukon. The Company has teamed up with two renowned gold producers that see vast potential in the district scale property and have made significant equity investments in the company. Analysts who cover the company believe that the firm is greatly undervalued and have issued "Buy" ratings and price targets that are far above the firm's current share price. Read part one of our two-part series.
Digital Prime Technologies reported that an affiliate of Cowen Inc. has completed a strategic investment in the company. Cowen plans to use Digital Prime's software to expand its prime brokerage capabilities in the digital asset sector to meet the rising demand from institutional clients.
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this energy company and recommends it to her social media following.
Dolly Varden Silver: Size Meets Grade (12/09/2021)
Dolly Varden Silver Corp. is positioning shareholders to have a commanding position on the southern tip of the Golden Triangle by acquiring the Homestake Ridge from Fury Gold Mines, along the Kitsault Valley Trend. The proposed amalgamation will position Dolly Varden Silver second to none in terms of size meets grade in precious metals.
Shares of Great Bear Resources Ltd. traded 24% higher after the company reported it entered into a definitive agreement to be acquired by Kinross Gold for CA$1.8 billion. Existing Great Bear shareholders will be given the option of receiving CA$29.00 per share in cash, shares in Kinross or a pro-rata combination of both, plus a contingent value right.
Pacific Ridge Hits Major Copper in British Columbia (12/09/2021)
Bob Moriarty of 321Gold shares his thoughts on his 18 years of experience with Pacific Ridge Exploration Ltd. and its current projects in British Colombia, Canada.
Humanigen has applications for lenzilumab in the works with U.S., United Kingdom and European drug regulatory agencies, noted a ROTH Capital Partners report.
Shares of contract research organization Inotiv Inc. traded higher after the company reported select preliminary unaudited financial results for Q4/21 and FY/21 which included a 90.7% YoY increase in revenue and a 123.0% increase in gross profit.
More than 80% of the supply of rare earth elements needed to make phones, laptops, laser-guided drones, and tech-heavy weapons is controlled by China. One North American-based explorer could challenge that dominance, according to a recently published preliminary economic assessment.
Harmony Biosciences Holdings intends to conduct a Phase Three trial next year to evaluate Wakix as a treatment for idiopathic hypersomnia, according to an Oppenheimer report.
"Silver X is one of the best positioned emerging junior silver producers in the market, with tremendous growth potential," noted a Red Cloud Securities report.
Shares of pet healthcare insurer Trupanion Inc. reached a new 52-week high after the company reported it is teaming up with Chewy Inc. to offer an exclusive line of pet wellness and health insurance products to Chewy's 20,000,000 customers.
Dolly Varden Buys Homestake Ridge From Fury (12/07/2021)
Bob Moriarty of 321 Gold shares his thoughts on Dolly Varden Silver Corp.'s Dec. 6 news of its planned acquisition of the Homestake Ridge gold/silver project from Fury Gold Mines Ltd.
In a Streetwise Live! Broadcast on Dec. 6, 2021, Stifel analyst Stephen Soock noted why now is a good time to invest in gold and, specifically, in White Gold Corp. Two of the companies' executives, David D'Onofrio, CEO, and Shawn Ryan, co-founder and technical adviser, shared what differentiates this exploration company from others and what it offers investors.
White Gold Gets Infusion of Capital, Knowledge (12/06/2021)
White Gold Corp. will use an investment of CA$9 million through strategic partner and investor Agnico Eagle Mines Ltd. for working capital and general corporate purposes. But the transaction has another benefit: It gives White Gold access to a tremendous level of expertise across all areas of mining.
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted.
New clinical trials for G1 Therapeutics’ Cosela are “central to our investment thesis,” H.C. Wainright & Co. noted in a new research report.
"Solid tumors offers a substantial opportunity for Karyopharm Therapeutics' Xpovio (selinexor) that perhaps investors have not yet realized," noted an H.C. Wainwright & Co. report.
Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from its Phase 1 GLEAN Study of ADI-001, which the firm noted is the first-ever allogeneic, off-the-shelf, gamma delta CAR T investigational cell therapy.
Adrian Day, in the Global Analyst newsletter, reviews developments at several companies, three of his favorite large miners and one favorite junior, all of which he says are at very compelling levels to buy.
Precious metals expert Michael Ballanger discusses Fed actions and how they affect precious metals.
Shares of Marvell Technology established a new 52-week high after the infrastructure semiconductor solutions firm reported Q3/22 financial results than included a 61% increase in YoY revenue.
The Best Game for Telcos to Get Into (12/02/2021)
Gaming is an estimated $192 billion market, and it is forecasted to grow to almost $400 billion by 2026. Sophic Capital makes the case that telcos need to evolve from being utilities to offering gaming services to attract and keep Gen-Z subscribers.
Legible Inc. began trading on the Canadian Stock Exchange under the ticker symbol READ after a three-way amalgamation closed.
Golden Sky Minerals Corp.'s stock rose almost 20% on volume exceeding 43,000 shares in intraday trading on the strength of drill reports on a Yukon property.
EnCore Energy's acquisition of Azarga Uranium is expected to close shortly, according to a Red Cloud Securities report.
The Critical Investor discusses the benefits of the recently acquired Con Mine with Gold Terra Executive Chairman Gerald Panneton.
Ambarella Inc. shares traded nearly 20% higher after the company reported Q3/22 financial results that included a 64% increase in YoY revenue together with higher gross margins.
|"DCM reported Q3/22 revenue of $63.4M, up 11.4% from $56.9M in Q3/21."|
|"EMO's Romanera offers significant upside potential for investors."|
|"LIO announced some more fabulous gold assays from the deep 500 zone."|
|"DV ownership is almost totally in the hands of professional investors."|
|"This is a good point to add to positions or make new purchases of RHQ."|